Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Merit Medical Systems, Inc. has announced the enrollment ...
Medical device company Merit Medical Systems (NASDAQ:MMSI) announced in Q1 CY2025, with sales up 9.8% year on year to $355.4 million. The company expects the full year’s revenue to be around $1.48 ...
Merit Medical Systems, Inc. announced that it will release its financial results for the quarter ending June 30, 2025, after the market closes on July 30, 2025. An investor conference call is ...
Exclusive agreement expands Medtronic's comprehensive pain interventions portfolio, increases treatment options for patients living with chronic pain GALWAY, Ireland, March 24, 2026 /PRNewswire/ -- ...
Hosted on MSN
Merit Medical Systems outlines 2025 revenue guidance of 10–11% growth and updates WRAPSODY reimbursement timeline
Earnings Call Insights: Merit Medical Systems, Inc. (MMSI) Q2 2025 CEO Fred P. Lampropoulos reported total revenue of $382.5 million for Q2 2025, representing a 13% year-over-year increase on a GAAP ...
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which ...
SOUTH JORDAN, Utah, April 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results